<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The renal and cerebral protective effects of <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> were assessed in normoalbuminuric patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 68 normoalbuminuric type 2 DM patients were enrolled in a one-year open-label randomized controlled trial: 34 patients (<z:chebi fb="0" ids="8228">pioglitazone</z:chebi>-<z:chebi fb="0" ids="6801">metformin</z:chebi>) vs. 34 patients (<z:chebi fb="0" ids="5383">glimepiride</z:chebi>-<z:chebi fb="0" ids="6801">metformin</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were assessed concerning urinary albumin: <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (UACR), urinary alpha1-microglobulin, urinary beta2-microglobulin, plasma asymmetric dymethyl-arginine (ADMA), GFR, hsC-reactive protein, fibrinogen, HbA1c; pulsatility index, resistance index in the internal carotid artery and middle cerebral artery, intima-media thickness in the common carotid artery; cerebrovascular reactivity was evaluated through the breath-holding test </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: At 1 year there were differences between groups regarding ADMA, urinary beta2-microglobulin, urinary alpha1-microglobulin, parameters of <z:mp ids='MP_0001845'>inflammation</z:mp>, serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, GFR, UACR, the cerebral haemodynamic indices </plain></SENT>
<SENT sid="4" pm="."><plain>Significant correlations were found between alpha 1-microglobulin-UACR (R(2)=0.143; P=0.001) and GFR (R(2)=0.081; P=0.01); beta2-microglobulin-UACR (R(2)=0.241; P=0.0001) and GFR (R(2)=0.064; P=0.036); ADMA-GFR (R(2)=0.338; P=0.0001), parameters of <z:mp ids='MP_0001845'>inflammation</z:mp>, HbA1c, duration of DM, cerebral indices </plain></SENT>
<SENT sid="5" pm="."><plain>There were no correlations between ADMA-UACR, urinary alpha1-microglobulin and beta2-microglobulin </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Proximal tubule (PT) dysfunction precedes <z:mp ids='MP_0002871'>albuminuria</z:mp> and is dissociated from <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in patients with type 2 DM </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="8228">Pioglitazone</z:chebi> delays PT dysfunction and improves cerebral vessels <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in normoalbuminuric patients with type 2 DM </plain></SENT>
</text></document>